What Artiva Biotherapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 19 | 22 |
| Sells | 6 | 14 |
| Total trades | 27 | 58 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 2,137,862 | 12,255,941 |
| Disposed | 90,396 | 216,487 |
| Net activity | +2,047,466 | +12,039,454 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Aslan Fred | Chief Executive Officer | Sep 03 | Sale for tax withholding · S | −61,888 | $11.16 | −$690K | 1,473,194 |
| Banerjee Subhashis | Chief Medical Officer | Sep 03 | Sale for tax withholding · S | −1,100 | $11.16 | −$12.3K | 140,947 |
| Bush Jennifer | COO, CLO, Compliance Officer | Sep 03 | Sale for tax withholding · S | −8,391 | $11.16 | −$93.6K | 329,529 |
| Horan Christopher | Chief Tech Operations Officer | Sep 03 | Sale for tax withholding · S | −10,366 | $11.16 | −$116K | 283,084 |
| Banerjee Subhashis | Chief Medical Officer | Aug 27 | Open-market sale · S | −8,222 | $12.01 | −$98.7K | 142,047 |
| Banerjee Subhashis | Chief Medical Officer | Aug 27 | Exercise / conversion · M | +5,306 | $1.92 | +$10.2K | 150,269 |
| Banerjee Subhashis | Chief Medical Officer | Aug 18 | Open-market sale · S | −429 | $12.00 | −$5.15K | 144,963 |
| Banerjee Subhashis | Chief Medical Officer | Aug 18 | Exercise / conversion · M | +429 | $1.92 | +$824 | 145,392 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 31 | Open-market buy · P | +24,944 | $9.93 | +$248K | 17,329,570 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 29 | Open-market buy · P | +20,824 | $9.99 | +$208K | 17,304,626 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 24 | Open-market buy · P | +41,319 | $9.99 | +$413K | 17,283,802 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 23 | Open-market buy · P | +59,880 | $9.96 | +$596K | 17,242,483 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 22 | Open-market buy · P | +84,124 | $9.93 | +$835K | 17,182,603 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 21 | Open-market buy · P | +120,582 | $9.55 | +$1.15M | 17,098,479 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 17 | Open-market buy · P | +7,882 | $8.95 | +$70.5K | 16,977,927 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 16 | Open-market buy · P | +152,472 | $8.93 | +$1.36M | 16,970,045 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 13 | Open-market buy · P | +6,552 | $8.94 | +$58.6K | 16,817,573 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 13 | Open-market buy · P | +6,522 | $8.94 | +$58.3K | 16,817,543 |
| Ra Capital MANAGEMENT, L.p. | Director | Jul 10 | Open-market buy · P | +15,102 | $8.97 | +$135K | 16,811,021 |
| Ra Capital MANAGEMENT, L.p. | Director | Jun 26 | Open-market buy · P | +1,876 | $8.98 | +$16.8K | 16,795,919 |
Loading...